Diamond Headache Clinic

Recent papers from Diamond Headache Clinic

1. Integrated analysis of two randomized controlled trials of a digital therapeutic for episodic migraine preventionnpj Digital Medicine · 2026
2. Mandibular Asymmetry in Cleft Lip and Palate Versus Class I Malocclusion: A Panoramic Radiographic Study in MosulSulaimani dental journal · 2026
3. Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi processExpert Opinion on Pharmacotherapy · 2026
4. Carotid Artery Stenting Outcomes in Comprehensive Stroke Hospitals (CASSH): A Prospective Multicenter StudyStroke Vascular and Interventional Neurology · 2026
5. Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic IndicationsPain and Therapy · 2026
6. SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic IndicationToxins · 2024
7. Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart ReviewPain and Therapy · 2024
8. Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort studyHeadache The Journal of Head and Face Pain · 2024
9. Efficacy and safety of metamizole sodium for pain syndrome in adults and children: a systematic reviewRussian Journal of Pain · 2024
10. Efficacy and Safety of Fremanezumab in Patients with Migraine and Obesity: Post Hoc Analysis of the Phase 3 HALO-LTS and FOCUS Clinical Trials (P8-12.001)Neurology · 2024
11. Change in Migraine Based on a Patient Global Impression of Change in Participants with Episodic Migraine and Chronic Migraine: Results from 5 Atogepant Clinical Trials (P8-12.006)Neurology · 2024
12. Real-world Evidence of Adding Atogepant to OnabotulinumtoxinA for Control of Chronic Migraine: A Retrospective Chart Review (P4-12.001)Neurology · 2024
13. Evaluation of PRF and PLA–PGA Membrane Along with Hydroxyapatite Crystal Collagen Fibers Bone Graft in the Treatment of Infrabony DefectsThe Journal of Contemporary Dental Practice · 2023
14. Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A reviewMedicine · 2023
15. Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trialHeadache The Journal of Head and Face Pain · 2023
16. Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trialCephalalgia · 2023
17. Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part IIArquivos de Neuro-Psiquiatria · 2022
18. Consensus of the Brazilian Headache Society (SBCe) for the Prophylactic Treatment of Episodic Migraine: part IArquivos de Neuro-Psiquiatria · 2022
19. Managing migraine on the frontline: Identifying disease, understanding burden, and incorporating CGRP pathway-targeting therapies in primary careBritish Journal of Pain · 2022
20. The importance of an early onset of migraine preventive disease control: A roundtable discussionThe Medicine Forum · 2022